In antagonist mode, 1α, 25-Dihydroxy Vitamin D3 (3 nM, final concentration) was added immediately after test compound addition.
After 6 h of incubation, 1 mL of normal growth medium containing twice the normal serum concentration was added without removing the transfection mixture.
Lysozyme (1 mg ml−1 final concentration) was added and samples were incubated at 37 °C for 45 min while slightly shaken.
Small plateaus were allowed before next concentration was added.
On day 1, silver nanoparticle at different concentration was added.
Lipase solution with specific concentration was added into the stirred buffer and the frequency change by time was recorded.
To produce this nanocomposite of GO sheets, glycine with known concentration was added to GO suspension in ethanol solvent.
Extract solution (0.05 ml) at different concentration was added to 0.95 ml of 0.1 mM DPPH in ethanol.
The negative effect means that if the EFB concentration was added on a decreasing trend, the CD could be improved.
To produce this nanocomposite with GO surface, glycine with known concentration was added to GO suspension in ethanol solvent.
Subsequently, an excess urea (67 mmol, five times of Zn/Al salt concentration) was added to adjust the pH and to reduce GO through urea hydrolysis under microwave.
